Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Cash from Investing Activities (2023)

Mangoceuticals' Cash from Investing Activities history spans 1 years, with the latest figure at -$3519.0 for Q1 2023.

  • For Q1 2023, Cash from Investing Activities changed N/A year-over-year to -$3519.0; the TTM value through Dec 2023 reached -$3519.0, changed N/A, while the annual FY2024 figure was $65000.0, 1947.12% up from the prior year.
  • Cash from Investing Activities for Q1 2023 was -$3519.0 at Mangoceuticals.
  • Across five years, Cash from Investing Activities topped out at -$3519.0 in Q1 2023 and bottomed at -$3519.0 in Q1 2023.